Skip to main content

Blossom Health

Category: AI in Healthcare

An AI-native operating system for psychiatry that automates administrative workflows and provides clinical copilots to transform episodic mental healthcare into a continuous, data-driven relationship. Blossom Health was founded in 2024. The company is led by John Zhao. Based in New York City, USA. Team size: 11-50. Total funding raised: $20.0M. Latest round: Series A ($20.0M, Mar 2026). Key investors include ["Headline","General Catalyst","Village Global","TA Ventures","Correlation Ventures","Operator Partners"].

Founded
2024
Headquarters
New York City, USA
Team size
11-50
Total funding
$20.0M

Value proposition

Reduces clinician burnout by automating 'back-office' tasks while improving patient outcomes through AI-driven continuous monitoring and clinical decision support between sessions.

Products and solutions

["AI Clinical Copilot (Diagnostic and treatment plan assistance)","Agentic AI Patient Monitoring (Text-based check-ins for sleep, mood, and medication adherence)","Automated Administrative Suite (AI-powered billing, documentation, and scheduling)","In-network Virtual Psychiatry Network"]

Unique value

Unlike generic EHRs or telehealth platforms, Blossom is 'AI-native,' using autonomous agents to bridge the gap between monthly appointments, turning episodic care into a continuous feedback loop.

Target customer

Independent psychiatrists, psychiatric group practices, and mental health patients seeking in-network care.

Industries served

["Healthcare","Mental Health & Psychiatry","Telemedicine","Artificial Intelligence"]

Technology advantage

Proprietary 'agentic' AI substrate that orchestrates interactions between psychiatrists, patients, and payors, significantly reducing the time-to-care (often same-day) and lowering patient costs through broad insurance integration.

How they differentiate

Blossom Health differentiates itself as an 'AI-native' operating system rather than just a telehealth provider or a marketplace. It utilizes agentic AI to automate the entire 'back-office' (billing, scheduling, insurance) and provides a clinical copilot that assists psychiatrists with diagnostics and continuous patient monitoring between sessions, whereas competitors like Headway focus primarily on insurance/billing and Talkiatry on clinical services.

Main competitors

["Talkiatry","Osmind","Headway"]

Key partnerships

["Headline (Lead Investor)","General Catalyst (Lead Investor)","Major Insurers (Optum/UnitedHealthcare, Aetna, Cigna, Blue Cross Blue Shield)","Healthie & Bridge (Infrastructure/API partners)","Sword Health (Strategic investor/collaborator)"]

Notable customers

["Optum","Aetna","Cigna","Blue Cross Blue Shield","Healthie (Case Study Partner)"]

Major milestones

["Founded in 2024 by John Zhao and Yury Yakubchyk","Emerged from stealth with $18.4M in initial funding in October 2025","Announced $20M in combined Seed and Series A funding in March 2026","Surpassed 10,000 patient treatment milestone in early 2026"]

Growth metrics

Treated over 10,000 patients within two years of founding; expanded operations to multiple U.S. states; achieved full operational status within three months of infrastructure setup.

Market positioning

AI-native telepsychiatry platform and clinical operating system provider

Geographic focus

United States (expanding nationwide)

Patents and IP

No specific patents disclosed; utilizes proprietary AI models and clinical workflows integrated with API-first healthcare infrastructure.

About John Zhao

John Zhao is a repeat entrepreneur and product leader with a track record of scaling multi-billion dollar healthcare and technology companies. Prior to founding Blossom Health, he served as VP of Product and General Manager at Athelas (which merged with Commure at a $6B valuation). He was also the VP of Product for New Ventures at EverQuote, where he was a key member of the leadership team that scaled the company through its successful IPO. Earlier in his career, he worked as a Private Equity Investment Analyst at Audax Group.

Official website: